InsidersTradesSigma
Follow the Vascular Biogenics Ltd. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was filed on 18 April 2023 (Levée d'options). Among the most active insiders: Backenroth Samuel. All data is free.
Analysts rate Vascular Biogenics Ltd. Buy (bullish), based on 8 analysts. Average price target: US$118.75.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Vascular Biogenics Ltd. 是一家生物制药公司，专注于开发血管疾病的治疗方法。该公司在纳斯达克上市。